Past, present, and future of genetic research in borderline personality disorder
Copyright © 2017 Elsevier Ltd. All rights reserved..
Borderline Personality Disorder (BPD) is a major mental illness with a lifetime prevalence of approximately 1-3%, characterized by a persistent pattern of instability in relationships, mood, impulse regulation, and sense of self. This results in impulsive self-damaging behavior, high suicide rates, and severe functional impairment. BPD has a complex, multifactorial etiology, resulting from an interaction among genetic and environmental substrates, and has moderate to high heritability based on twin and family studies. However, our understanding of the genetic architecture of BPD is very limited. This is a critical obstacle since genetics can pave the way for identifying new treatment targets and developing preventive and disease-modifying pharmacological treatments which are currently lacking. We review genetic studies in BPD, with a focus on limitations and challenges and future directions. Genetic research in BPD is still in its very early stages compared to other major psychiatric disorders. Most early genetic studies in BPD were non-replicated association studies in small samples, focused on single candidate genes. More recently, there has been one genome-wide linkage study and a genome-wide association study (GWAS) of subclinical BPD traits and a first GWAS in a relatively modest sample of patients fulfilling full diagnostic criteria for the disorder. Although there are adequate animal models for some of the core dimensions of BPD, there is a lack of translational research including data from animal models in BPD. Research in more pioneering fields, such as imaging genetics, deep sequencing and epigenetics, holds promise for elucidating the pathophysiology of BPD and identifying new treatment targets.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
---|---|
Enthalten in: |
Current opinion in psychology - 21(2018) vom: 15. Juni, Seite 60-68 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Bassir Nia, Anahita [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Completed 04.04.2019 Date Revised 05.11.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.copsyc.2017.09.002 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM277008301 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM277008301 | ||
003 | DE-627 | ||
005 | 20231225013241.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.copsyc.2017.09.002 |2 doi | |
028 | 5 | 2 | |a pubmed24n0923.xml |
035 | |a (DE-627)NLM277008301 | ||
035 | |a (NLM)29032046 | ||
035 | |a (PII)S2352-250X(17)30198-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Bassir Nia, Anahita |e verfasserin |4 aut | |
245 | 1 | 0 | |a Past, present, and future of genetic research in borderline personality disorder |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.04.2019 | ||
500 | |a Date Revised 05.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2017 Elsevier Ltd. All rights reserved. | ||
520 | |a Borderline Personality Disorder (BPD) is a major mental illness with a lifetime prevalence of approximately 1-3%, characterized by a persistent pattern of instability in relationships, mood, impulse regulation, and sense of self. This results in impulsive self-damaging behavior, high suicide rates, and severe functional impairment. BPD has a complex, multifactorial etiology, resulting from an interaction among genetic and environmental substrates, and has moderate to high heritability based on twin and family studies. However, our understanding of the genetic architecture of BPD is very limited. This is a critical obstacle since genetics can pave the way for identifying new treatment targets and developing preventive and disease-modifying pharmacological treatments which are currently lacking. We review genetic studies in BPD, with a focus on limitations and challenges and future directions. Genetic research in BPD is still in its very early stages compared to other major psychiatric disorders. Most early genetic studies in BPD were non-replicated association studies in small samples, focused on single candidate genes. More recently, there has been one genome-wide linkage study and a genome-wide association study (GWAS) of subclinical BPD traits and a first GWAS in a relatively modest sample of patients fulfilling full diagnostic criteria for the disorder. Although there are adequate animal models for some of the core dimensions of BPD, there is a lack of translational research including data from animal models in BPD. Research in more pioneering fields, such as imaging genetics, deep sequencing and epigenetics, holds promise for elucidating the pathophysiology of BPD and identifying new treatment targets | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Review | |
700 | 1 | |a Eveleth, Matthew C |e verfasserin |4 aut | |
700 | 1 | |a Gabbay, Jonathan M |e verfasserin |4 aut | |
700 | 1 | |a Hassan, Yonis J |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Bosi |e verfasserin |4 aut | |
700 | 1 | |a Perez-Rodriguez, M Mercedes |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current opinion in psychology |d 2015 |g 21(2018) vom: 15. Juni, Seite 60-68 |w (DE-627)NLM245860509 |x 2352-2518 |7 nnns |
773 | 1 | 8 | |g volume:21 |g year:2018 |g day:15 |g month:06 |g pages:60-68 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.copsyc.2017.09.002 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 21 |j 2018 |b 15 |c 06 |h 60-68 |